Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-016203
Filing Date
2022-05-02
Accepted
2022-05-02 21:15:11
Documents
1
Period of Report
2022-04-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 12452
  Complete submission text file 0000899243-22-016203.txt   13868
Mailing Address 12860 EL CAMINO REAL, SUITE 300 SAN DIEGO CA 92130
Business Address
Davis Aaron I. (Reporting) CIK: 0001465914 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39401 | Film No.: 22884275

Mailing Address 321 ARSENAL STREET BLDG 312, FLOOR 3, SUITE 301 WATERTOWN MA 02472
Business Address 321 ARSENAL STREET BLDG 312, FLOOR 3, SUITE 301 WATERTOWN MA 02472 857-204-4583
iTeos Therapeutics, Inc. (Issuer) CIK: 0001808865 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)